E Martí-Guadaño

A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items

Antonio Valero, Montse Ferrer, J. Sastre et al. · Journal of Allergy and Clinical Immunology · 2007 · 117 citations

Life Sciences, Immunology, Otolaryngology +17

Health‐related quality of life in allergic rhinitis: comparing the short form ESPRINT‐15 and MiniRQLQ questionnaires

Antonio Valero, Jordi Alonso, I. Antépara et al. · Allergy · 2007 · 58 citations

Life Sciences, Otolaryngology, Allergy +16

Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.

C. Martínez‐Cócera, M De Molina, E Martí-Guadaño et al. · PubMed · 2005 · 45 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

Antonio Valero, Montse Ferrer, Eva Baró et al. · Allergy · 2010 · 37 citations

Life Sciences, Immunology, Internal Medicine +11

Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version).

Antonio Valero, Eva Baró, J. Sastre et al. · PubMed · 2009 · 23 citations

Life Sciences, Psychology, Allergy +11